Krsnaa Diagnostics has announced a board meeting to consider the financial results for the quarter and half-year. The board has proposed a final dividend of ₹2.75 per share (55% of face value) for FY 2024-25, pending shareholder approval at the AGM. With consolidated net profit at ₹77.6 Cr, this signals a strong shareholder return. Approval and payment details will follow post-AGM, providing income-focused investors an attractive payout opportunity.